Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Psoriasis: talking points from recent clinical trials.
Chiricozzi A, Bellinato F, Romita P, Gisondi P. Chiricozzi A, et al. Expert Opin Investig Drugs. 2022 Dec;31(12):1265-1267. doi: 10.1080/13543784.2022.2160314. Epub 2022 Dec 25. Expert Opin Investig Drugs. 2022. PMID: 36526606 No abstract available.
Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis.
Gisondi P, Altomare G, Ayala F, Bardazzi F, Bianchi L, Chiricozzi A, Costanzo A, Conti A, Dapavo P, De Simone C, Foti C, Naldi L, Offidani A, Parodi A, Piaserico S, Prignano F, Rongioletti F, Stingeni L, Talamonti M, Girolomoni G. Gisondi P, et al. Among authors: chiricozzi a. J Eur Acad Dermatol Venereol. 2017 May;31(5):774-790. doi: 10.1111/jdv.14114. Epub 2017 Feb 27. J Eur Acad Dermatol Venereol. 2017. PMID: 28244153
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience.
Conti A, Peccerillo F, Amerio P, Balato A, Bardazzi F, Bianchi L, Burlando M, Cannavò SP, Chiricozzi A, Dapavo P, De Simone C, Fargnoli MC, Gambardella A, Gisondi P, Malagoli P, Malara G, Mugheddu C, Offidani AM, Piaserico S, Prignano F, Stingeni L, Pellacani G. Conti A, et al. Among authors: chiricozzi a. Br J Dermatol. 2019 Jun;180(6):1547-1548. doi: 10.1111/bjd.17580. Epub 2019 Feb 21. Br J Dermatol. 2019. PMID: 30578668 No abstract available.
Consensus on the place in therapy of TNF-α inhibitors in the treatment of patients with chronic plaque psoriasis.
Gisondi P, Bellinato F, Conti A, Dapavo P, Piaserico S, De Simone C, Chiricozzi A, Dattola A, Malagoli P, Malara G, Campanati A, Burlando M, Esposito M, Gallo L, Girolomoni G. Gisondi P, et al. Among authors: chiricozzi a. J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e470-e472. doi: 10.1111/jdv.16380. Epub 2020 May 20. J Eur Acad Dermatol Venereol. 2020. PMID: 32189348 No abstract available.
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study.
Dattola A, Balato A, Megna M, Gisondi P, Girolomoni G, De Simone C, Caldarola G, Cama E, Piaserico S, Fargnoli MC, Fidanza R, Parodi A, Burlando M, Offidani A, Diotallevi F, Potenza C, Conti A, Chiricozzi A, Campione E, Bianchi L. Dattola A, et al. Among authors: chiricozzi a. J Eur Acad Dermatol Venereol. 2020 Dec;34(12):2839-2845. doi: 10.1111/jdv.16606. Epub 2020 Jun 26. J Eur Acad Dermatol Venereol. 2020. PMID: 32401377
Baricitinib: therapeutic potential for moderate to severe atopic dermatitis.
Calabrese L, Malvaso D, Chiricozzi A, Tambone S, D'Urso DF, Guerriero C, Peris K. Calabrese L, et al. Among authors: chiricozzi a. Expert Opin Investig Drugs. 2020 Oct;29(10):1089-1098. doi: 10.1080/13543784.2020.1800639. Epub 2020 Aug 14. Expert Opin Investig Drugs. 2020. PMID: 32703039 Review.
221 results